相关实验视频

Updated: Jun 30, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

针对HPV相关恶性瘤的mRNA治疗疫苗的免疫性和有效性

Jing Wang¹, Ling Ma¹, Yunfeng Chen²

¹Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China.

Life science alliance

|March 21, 2024

概括

一种新的mRNA治疗疫苗 (mHTV-02) 有效向高风险的HPV感染. 在临床前模型中,肌内或内输送显示出显著的瘤回归和改善的生存率.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

人类乳头瘤病毒 (HPV) 感染与许多癌症有关.
现有的预防性疫苗对先前存在的高风险HPV (16和18) 感染和病变无效.
治疗性疫苗对于治疗HPV驱动的恶性瘤至关重要.

研究的目的:

开发和评估一种基于mRNA的脂质纳米颗粒配方的HPV治疗疫苗 (mHTV-02).
评估mHTV-02对HPV16和HPV18E6/E7型蛋白的疗效.
为了确定mHTV-02治疗的最佳给药途径.

主要方法:

开发mHTV-02,一种针对HPV16/18 E6/E7.7的mRNA疫苗.
在TC-1瘤小鼠模型中评估免疫反应,包括T细胞透和细胞毒性.
肌内,肌内和静脉注射后治疗效果的比较.

主要成果:

mHTV-02在小鼠中诱导了强大的抗原特异性细胞和记忆T细胞免疫力.
在TC-1瘤中观察到显著的CD8+T细胞透和细胞毒性.
肌内和内注射导致瘤回归和延长存活时间.
静脉输送显示了最小的治疗益处.

结论:

mHTV-02对HPV16/18驱动的癌症表现出强大的抗瘤活性.
特定的注射途径 (肌内注射,内注射) 对疫苗的疗效至关重要.
mHTV-02是一个有前途的治疗性mRNA疫苗候选人,用于HPV相关的恶性瘤.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.